Literature DB >> 12687533

Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification.

Elizabeth K Rasch1, Rosemarie Hirsch, Ryne Paulose-Ram, Marc C Hochberg.   

Abstract

OBJECTIVE: To determine prevalence estimates for rheumatoid arthritis (RA) in noninstitutionalized older adults in the US. Prevalence estimates were compared using 3 different classification methods based on current classification criteria for RA.
METHODS: Data from the Third National Health and Nutrition Examination Survey (NHANES-III) were used to generate prevalence estimates by 3 classification methods in persons 60 years of age and older (n = 5,302). Method 1 applied the "n of k" rule, such that subjects who met 3 of 6 of the American College of Rheumatology (ACR) 1987 criteria were classified as having RA (data from hand radiographs were not available). In method 2, the ACR classification tree algorithm was applied. For method 3, medication data were used to augment case identification via method 2. Population prevalence estimates and 95% confidence intervals (95% CIs) were determined using the 3 methods on data stratified by sex, race/ethnicity, age, and education.
RESULTS: Overall prevalence estimates using the 3 classification methods were 2.03% (95% CI 1.30-2.76), 2.15% (95% CI 1.43-2.87), and 2.34% (95% CI 1.66-3.02), respectively. The prevalence of RA was generally greater in the following groups: women, Mexican Americans, respondents with less education, and respondents who were 70 years of age and older.
CONCLUSION: The prevalence of RA in persons 60 years of age and older is approximately 2%, representing the proportion of the US elderly population who will most likely require medical intervention because of disease activity. Different classification methods yielded similar prevalence estimates, although detection of RA was enhanced by incorporation of data on use of prescription medications, an important consideration in large population surveys.

Entities:  

Mesh:

Year:  2003        PMID: 12687533     DOI: 10.1002/art.10897

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  63 in total

Review 1.  Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.

Authors:  M C Hochberg; J K Tracy; M Hawkins-Holt; R H Flores
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.

Authors:  Thurayya Arayssi; Manale Harfouche; Andrea Darzi; Samar Al Emadi; Khalid A Alnaqbi; Humeira Badsha; Farida Al Balushi; Carole Dib; Bassel Elzorkany; Hussein Halabi; Mohammed Hammoudeh; Wissam Hazer; Basel Masri; Mira Merashli; Mohammed Omair; Nelly Salloum; Imad Uthman; Sumeja Zahirovic; Nelly Ziade; Raveendhara R Bannuru; Timothy McAlindon; Mohamed A Nomier; Jasvinder A Singh; Robin Christensen; Peter Tugwell; Holger Schünemann; Elie A Akl
Journal:  Clin Rheumatol       Date:  2018-08-10       Impact factor: 2.980

Review 3.  Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Authors:  Iris Navarro-Millán; Jasvinder A Singh; Jeffrey R Curtis
Journal:  Clin Ther       Date:  2012-03-22       Impact factor: 3.393

4.  Interstitial lung disease in rheumatoid arthritis.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

5.  TDP-43 frontotemporal lobar degeneration and autoimmune disease.

Authors:  Zachary A Miller; Katherine P Rankin; Neill R Graff-Radford; Leonel T Takada; Virginia E Sturm; Clare M Cleveland; Lindsey A Criswell; Philipp A Jaeger; Trisha Stan; Kristin A Heggeli; Sandy Chan Hsu; Anna Karydas; Baber K Khan; Lea T Grinberg; Maria Luisa Gorno-Tempini; Adam L Boxer; Howard J Rosen; Joel H Kramer; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; William W Seeley; Tony Wyss-Coray; Bruce L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-30       Impact factor: 10.154

Review 6.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

7.  Personal and family medical history correlates of rheumatoid arthritis.

Authors:  Anneclaire J de Roos; Glinda S Cooper; Michael C Alavanja; Dale P Sandler
Journal:  Ann Epidemiol       Date:  2008-03-17       Impact factor: 3.797

8.  Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis.

Authors:  Abdou S El-Labban; Hanaa A S Abo Omar; Rawhya R El-Shereif; Fatma Ali; Tarek M El-Mansoury
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-05-20

9.  Frequency of inflammatory-like MR imaging findings in asymptomatic fingers of healthy volunteers.

Authors:  Christoph A Agten; Andrea B Rosskopf; Maciej Jonczy; Florian Brunner; Christian W A Pfirrmann; Florian M Buck
Journal:  Skeletal Radiol       Date:  2017-11-06       Impact factor: 2.199

10.  Shared epitope and radiologic progression are less prominent in elderly onset RA than young onset RA.

Authors:  Eun-Ji Kim; Jennifer Lee; Yang-Sun Ryu; Ji-Min Kim; Yong-Geun Jeong; Seung-Ki Kwok; Ji-Hyeon Ju; Kyung-Su Park; Sung-Hwan Park; Hee-Baeg Choi; Tai-Gyu Kim; Ho-Youn Kim
Journal:  Rheumatol Int       Date:  2013-02-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.